201Thallium SPECT and 1H-MRS compared with MRI in chemotherapy monitoring of high-grade malignant astrocytomas

Journal of Neuro-Oncology

Volumn 46, Issue 2, 2000, Pages 173-185

  Kallen K ^a   Burtscher, I M ^a   Holtas S ^a   Ryding, E ^a   Rosen I ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

201Thallium SPECT; Astrocytoma; Chemotherapy; MR spectroscopy; MRI

Indexed keywords

LOMUSTINE; PROCARBAZINE; THALLIUM 201; VINCRISTINE; ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; THALLIUM;

ADULT; ARTICLE; ASTROCYTOMA; CLINICAL ARTICLE; COMPARATIVE STUDY; DRUG EFFICACY; DRUG MONITORING; EVALUATION; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; TUMOR PROMOTION; TUMOR VOLUME; BRAIN TUMOR; CASE REPORT; CLINICAL TRIAL; DISEASE COURSE; FOLLOW UP; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SENSITIVITY AND SPECIFICITY; STANDARD;

ADULT; ANTINEOPLASTIC AGENTS; ASTROCYTOMA; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033623827     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006429329677     Document Type: Article

References (37)

1. Byrne TN: Imaging of gliomas. Semin Oncol 21(2): 162-171, 1994
2. Kaplan RS: Complexities, pitfalls, and strategies for evaluating brain tumor therapies. Curr Opin Oncol 10(3): 175-178, 1998
3. Perry JR, DeAngelis LM, Schold SC, Jr., Burger PC, Brem H, Brown MT et al.: Challenges in the design and conduct of phase III brain tumor therapy trials. Neurology 49(4): 912-917, 1997
4. Cairncross JG, Pexman JH, Rathbone MP, DelMaestro RF: Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 17(6): 570-572, 1985
5. Tamura M, Shibasaki T, Zama A, Kurihara H, Horikoshi S, Ono N et al.: Assessment of malignancy of glioma by positron emission tomography with 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride. Neuroradiology 40(4): 210-251, 1998
6. Taguchi A: Clinical significance of thallium-201 single-photon emission computerized tomography (Tl-201 SPECT) in the evaluation of viability of gliomas. Kurume Med J 39(4): 267-278, 1992
7. Kim KT, Black KL, Marciano D, Mazziotta JC, Guze BH, Grafton S et al.: Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med 31(6): 965-969, 1990
8. 201Tl SPECT). Nucl Med Commun 14(12): 1050-1060, 1993
9. Mountz JM, Stafford-Schuck K, McKeever PE, Taren J, Beierwaltes WH: Thallium-201 tumor/cardiac ratio estimation of residual astrocytoma. J Neurosurg 68(5): 705-709, 1998
10. Waldrop SM, Davis PC, Padgett CA, Shapiro MB, Morris R: Treatment of brain tumors in children is associated with abnormal MR spectroscopic ratios in brain tissue remote from the tumor site (see comments). AJNR Am J Neuroradiol 19(5): 963-970, 1998
11. Preul MC, Leblanc R, Caramanos Z, Kasrai R, Narayanan S, Arnold DL: Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases. Can J Neurol Sci 25(1): 13-22, 1998
12. 1H-spectroscopy: preliminary study. Anticancer Res 16(3B): 1581-1585, 1996
13. 1H-MRS) for the evaluation of treatment of brain tumors. Neuroradiology 37(2): 99-103, 1995
14. Kernohan JW, Mabon RF, Svein HJ, Adson AW: A simplified classification of gliomas. Proc Staff Meet Mayo Clinic 24: 71-75, 1949
15. Sandberg-Wollheim M, Malmstrom P, Stromblad LG, Anderson H, Borgstrom S, Brun A et al.: A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4. Cancer 68(1): 22-29, 1991
16. Sjoholm H, Elmqvist D, Rehncrona S, Rosen I, Salford LG: SPECT imaging of gliomas with Thallium-201 and Technetium-99m-HMPAO. Acta Neurol Scand 91(1): 66-70, 1995
17. Ueda T, Kaji Y, Wakisaka S, Watanabe K, Hoshi H, Jinnouchi S et al.: Time sequential single photon emission computed tomography studies in brain tumor using thallium-201. Eur J Nucl Med 20(2): 138-145, 1993
18. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D: Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 71(3): 342-346, 1989
19. Kallen K, Geijer MD, Andersson AM, Holtas S, Ryding E, Rosen I: Glioma viability assessment by Thallium-201 SPECT Tumor Uptake Volume (TUV) estimation. J Nucl Med Comm 1999 (in press)
20. Yoshii Y, Satou M, Yamamoto T, Yamada Y, Hyodo A, Nose T et al.: The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumors in man and their response to treatment. Eur J Nucl Med 20(1): 39-45, 1993
21. Carvalho PA, Schwartz RB, Alexander E, III, Garada BM, Zimmerman RE, Loeffler JS et al.: Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 77(4): 565-570, 1992
22. Zhang JJ, Park CH, Kim SM, Ayyangar KM, Haghbin M: Dual isotope SPECT in the evaluation of recurrent brain tumor. Clin Nucl Med 17(8): 663-664, 1992
23. 201Tl single photon emission tomography in the evaluation of residual and recurrent astrocytoma. Nucl Med Commun 15(3): 140-143, 1994
24. 201Tl and 99mTc-HMPAO. AJNR Am J Neuroradiol 12(6): 1187-1192, 1991
25. 201Tl SPECT for differentiation of recurrent glioma from radiation necrosis. Neurol Med Chir (Tokyo) 38(6): 342-347, 1998
26. Lorberboym M, Baram J, Feibel M, Hercbergs A, Lieberman L: A prospective evaluation of thallium-201 single photon emission computerized tomography for brain tumor burden. Int J Radiat Oncol Biol Phys 32(1): 249-254, 1995
27. DeAngelis LM. Brain tumor therapy: new horizons, new hope (editorial; comment). Neurology 50(5): 1209-1210, 1998
28. DeAngelis LM, Burger PC, Green SB, Cairncross JG: Malignant glioma: who benefits from adjuvant chemotherapy? Ann Neurol 44(4): 691-695, 1998
29. Bloom M, Jacobs S, Pile-Spellman J, Pozniakoff A, Mabutas MI, Fawwaz RA et al.: Cerebral SPECT imaging: effect on clinical management. J Nucl Med 37(7): 1070-1073, 1993
30. Kallen K, Heiling M, Andersson AM, Brun A, Holtas S, Ryding E: Preoperative grading of glioma malignancy with thallium-201 single-photon emission CT: comparison with conventional CT. AJNR Am J Neuroradiol 17(5): 925-932, 1996
31. Kimura H, Takeno Y, Fukushima T: Variation in appearance ofglioma on serial thallium-201 single photon emission computed tomography - case report. Neurol Med Chir (Tokyo) 35(5): 317-320, 1995
32. Kallen K, Heiling M, Andersson AM, Brun A, Holtas S, Ryding E et al.: Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT. J Neurol Neurosurg Psychiatry 63(5): 569-574, 1997
33. Ricci M, Pantano P, Pierallini A, Di Stefano D, Santoro A, Bozzao L et al.: Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging. Eur J Nucl Med 23(5): 524-529, 1996
34. 201thallium-SPECT imaging in childhood brainstem gliomas. Pediatr Radiol 28(8): 575-579, 1998
35. Namba H, Togawa T, Yui N, Yanagisawa M, Kinoshita F, Iwadate Y et al.: The effect of steroid on thallium-201 uptake by malignant gliomas. Eur J Nucl Med 23(8): 991-992, 1996
36. Luyten PR, Marien AJ, Heindel W, van Gerwen PH, Herholz K, den Hollander JA et al.: Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 176(3): 791-799, 1990
37. 1H NMR spectroscopic imaging. Magn Reson Med 13(1): 62-76, 1990